Although it is clear that human chorionic gonadotropin (hCG) and progesterone play fundamental roles in pregnancy, the regulation of placental production of these hormones remains to be defined. Recent evidence suggests that the human placenta expresses proteins related to inhibin (afi subunits) or activin (8P subunits). Inhibin and activin (folliclestimulating hormone-releasing protein) possess opposing activities in several biological systems including pituitary folliclestimulating hormone (follitropin) secretion, erythroid differentiation, and gonadal sex-steroid production. The actions of purified inhibin and activin on hormonogenesis by primary cultures of human placental cells were studied. The addition of activin increased gonadotropin-releasing hormone (GnRH) and progesterone production and potentiated the GnRHinduced release of hCG. Inhibin by itself did not modify placental immunoreactive GnRH, hCG, and progesterone secretion but reversed the activin-induced changes. Neither inhibin nor activin influenced the release of human placental lactogen. Furthermore, transforming growth factor (3, structurally related to inhibin/activin, did not signifcantly influence hormone release from cultured placental cells. These results support the hypothesis that inhibin and activin may play a role in regulating the release of GnRH, hCG, and progesterone from placenta and implicate inhibin-related proteins in the endocrine physiology of human pregnancy.
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Inhibins are heterodimeric proteins, consisting of an a subunit and one of two ,8 subunits (13A or PB), that were originally identified based upon their abilities to selectively suppress follicle-stimulating hormone (FSH) secretion (1) (2) (3) (4) (5) (6) . FSHreleasing proteins or activins were subsequently isolated and characterized as dimers comprised of inhibin (3 subunits APA or AJB) (7, 8) . Although inhibin and activin were first isolated from the gonads, various tissues including the placenta contain inhibin subunit mRNAs (9) (10) (11) (12) . Whereas the gonads contain a large excess of a-over (B-chain mRNAs, the placenta has an excess of p-subunit mRNAs; such observations raise the possibility that the placenta might have a preponderance of,,8 dimers (12) . However, there is not yet conclusive evidence that intact activin is synthesized by human placenta.
Placental inhibin a-subunit immunoreactivity is localized in the cytotrophoblast layer of the villi (11), a region shown earlier to contain other regulatory peptides including gonadotropin-releasing hormone (GnRH; refs. [13] [14] [15] [16] [17] [18] [19] [20] , somatostatin (21) , and corticotropin-releasing factor (22) . The evidence that the placenta produces these hypophysiotropic peptides, which modulate the secretion of various hormones related to those in the pituitary [human chorionic gonadotropin (hCG), human placental lactogen (hPL), and corticotropin], supports the hypothesis that placental hormonogenesis may be regulated in part by locally produced peptides (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) .
A recent report (11) showed that the addition of inhibin antiserum increased hCG production in primary human placental cultures, suggesting that endogenous inhibin might tonically inhibit secretion of the placental gonadotropin. To evaluate the possible roles of inhibin-related proteins in the regulation of placental hormones more directly, we have investigated the effects-of inhibin and activin on the secretion of GnRH, hCG, and progesterone by cultured placental cells. Moreover, because inhibin and activin are structurally related to the transforming growth factor /3 (TGF-,3) family of growth factors (23) 
RESULTS
The addition of purified ovine inhibin to the cultured placental cells did not alter the basal secretion rate of hCG but reduced the GnRH-induced release of hCG (Fig. 1) . Activin, which only slightly and not significantly increased the release of hCG when added alone, strongly potentiated the stimulatory action of GnRH on hCG secretion (Fig. 2) . This effect was dose-related (Fig. 2) and was reversed by inhibin (Fig. 1) (Fig. 3) . Ihhibin did not significantly change progesterone concentration but completely reversed (90 pM) the effect of activin on progesterone release (Fig. 3 ). increases the release of GnRH and progesterone and augments the release of hCG induced by GnRH. Although inhibin alone does not directly affect the spontaneous secretion of the various placental hormones measured, the effects of activin on GnRH, hCG, and progesterone production were reversed by inhibin. These results agree with previous observations showing functional antagonism between inhibin and activin in various tissues. Indeed, the two dimers exert opposite effects on FSH release from pituitary gland (7), on androgen production by the gonads (29) , on the induction of hemoglobin synthesis in a human erythroleukemic cell line, and on cell proliferation in human bone marrow (30) . The evidence that neither dimer influenced the secretion of hPL and that moderate doses of the related protein, TGF-p, did not influence the release of the hormones from cultured placental cells supports the specificity of the actions of inhibin and activin in this system. There is immunologic and chromatographic evidence for the presence of inhibin in placental extracts and cultures (11) . Although activin has not yet been demonstrated to be produced in the placenta, the excess of /-subunit relative to a-subunit mRNAs in that tissue (12) tion of f3f rather than a8 dimers (31) . The presence of mRNAs for inhibin subunits in human placenta (9, 12) indicates that inhibin and activin could be locally produced. The effects of inhibin and activin on placental hormone release from cultured cells may reflect autocrine or paracrine effects of the locally produced peptides. Although an endocrine effect of circulating inhibin or activin cannot be excluded, the placenta itself has been shown to be the major source of circulating inhibin during pregnancy (32) .
Even though the actions of these dimers on placental functions remain to be explored in vivo, the present studies suggest that activin and inhibin, by modulating the secretion of placental GnRH, hCG, and progesterone, could play a role in the regulation of pregnancy.
